194 related articles for article (PubMed ID: 20932595)
1. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F
J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595
[TBL] [Abstract][Full Text] [Related]
2. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
Gao R; Gao W; Xu G; Xu J; Ren H
World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
[TBL] [Abstract][Full Text] [Related]
4. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants.
Catanese MT; Ansuini H; Graziani R; Huby T; Moreau M; Ball JK; Paonessa G; Rice CM; Cortese R; Vitelli A; Nicosia A
J Virol; 2010 Jan; 84(1):34-43. PubMed ID: 19828610
[TBL] [Abstract][Full Text] [Related]
5. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
Eyre NS; Drummer HE; Beard MR
PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
[TBL] [Abstract][Full Text] [Related]
6. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; Mangeot PE; Keck Z; Foung S; Vu-Dac N; Dubuisson J; Bartenschlager R; Lavillette D; Cosset FL
J Biol Chem; 2006 Jul; 281(27):18285-95. PubMed ID: 16675450
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor class B type I mediates cell entry of hepatitis C virus.
Jia ZS; Du DW; Lei YF; Wei X; Yin W; Ma L; Lian JQ; Wang PZ; Li D; Zhou YX
J Int Med Res; 2008; 36(6):1319-25. PubMed ID: 19094442
[TBL] [Abstract][Full Text] [Related]
8. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
Voisset C; Callens N; Blanchard E; Op De Beeck A; Dubuisson J; Vu-Dac N
J Biol Chem; 2005 Mar; 280(9):7793-9. PubMed ID: 15632171
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
10. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.
Catanese MT; Graziani R; von Hahn T; Moreau M; Huby T; Paonessa G; Santini C; Luzzago A; Rice CM; Cortese R; Vitelli A; Nicosia A
J Virol; 2007 Aug; 81(15):8063-71. PubMed ID: 17507483
[TBL] [Abstract][Full Text] [Related]
11. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.
Barth H; Cerino R; Arcuri M; Hoffmann M; Schürmann P; Adah MI; Gissler B; Zhao X; Ghisetti V; Lavezzo B; Blum HE; von Weizsäcker F; Vitelli A; Scarselli E; Baumert TF
J Virol; 2005 May; 79(9):5774-85. PubMed ID: 15827192
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.
Barth H; Schnober EK; Neumann-Haefelin C; Thumann C; Zeisel MB; Diepolder HM; Hu Z; Liang TJ; Blum HE; Thimme R; Lambotin M; Baumert TF
J Virol; 2008 Apr; 82(7):3466-79. PubMed ID: 18216094
[TBL] [Abstract][Full Text] [Related]
13. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
[TBL] [Abstract][Full Text] [Related]
14. CD36 is a co-receptor for hepatitis C virus E1 protein attachment.
Cheng JJ; Li JR; Huang MH; Ma LL; Wu ZY; Jiang CC; Li WJ; Li YH; Han YX; Li H; Chen JH; Wang YX; Song DQ; Peng ZG; Jiang JD
Sci Rep; 2016 Feb; 6():21808. PubMed ID: 26898231
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
16. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.
Zahid MN; Turek M; Xiao F; Thi VL; Guérin M; Fofana I; Bachellier P; Thompson J; Delang L; Neyts J; Bankwitz D; Pietschmann T; Dreux M; Cosset FL; Grunert F; Baumert TF; Zeisel MB
Hepatology; 2013 Feb; 57(2):492-504. PubMed ID: 23081796
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.
Zhu H; Wong-Staal F; Lee H; Syder A; McKelvy J; Schooley RT; Wyles DL
J Infect Dis; 2012 Feb; 205(4):656-62. PubMed ID: 22279172
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
[TBL] [Abstract][Full Text] [Related]
20. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
